These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
447 related articles for article (PubMed ID: 15671269)
1. Inhibitory effect of rapamycin on corneal neovascularization in vitro and in vivo. Kwon YS; Hong HS; Kim JC; Shin JS; Son Y Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):454-60. PubMed ID: 15671269 [TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of curcumin on corneal neovascularization in vitro and in vivo. Bian F; Zhang MC; Zhu Y Ophthalmologica; 2008; 222(3):178-86. PubMed ID: 18497527 [TBL] [Abstract][Full Text] [Related]
3. Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells. Ma X; Ottino P; Bazan HE; Bazan NG Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2915-21. PubMed ID: 15326102 [TBL] [Abstract][Full Text] [Related]
4. [Inhibition of growth and metastasis of hepatocellular carcinoma by rapamycin: experiment with mice]. Wang Z; Fan J; Zhou J; Wu ZQ; Qiu SJ; Yu Y; Huang XW; Tang ZY Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1666-70. PubMed ID: 16854316 [TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of canstatin in alkali burn-induced corneal neovascularization. Wang Y; Yin H; Chen P; Xie L; Wang Y Ophthalmic Res; 2011; 46(2):66-72. PubMed ID: 21242701 [TBL] [Abstract][Full Text] [Related]
6. Fractalkine, a CX3C chemokine, as a mediator of ocular angiogenesis. You JJ; Yang CH; Huang JS; Chen MS; Yang CM Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5290-8. PubMed ID: 17962485 [TBL] [Abstract][Full Text] [Related]
7. Endogenous TNFalpha suppression of neovascularization in corneal stroma in mice. Fujita S; Saika S; Kao WW; Fujita K; Miyamoto T; Ikeda K; Nakajima Y; Ohnishi Y Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):3051-5. PubMed ID: 17591872 [TBL] [Abstract][Full Text] [Related]
8. Chemical injury-induced corneal opacity and neovascularization reduced by rapamycin via TGF-β1/ERK pathways regulation. Shin YJ; Hyon JY; Choi WS; Yi K; Chung ES; Chung TY; Wee WR Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4452-8. PubMed ID: 23716625 [TBL] [Abstract][Full Text] [Related]
9. A siRNA targeting vascular endothelial growth factor-A inhibiting experimental corneal neovascularization. Zuo L; Fan Y; Wang F; Gu Q; Xu X Curr Eye Res; 2010 May; 35(5):375-84. PubMed ID: 20450250 [TBL] [Abstract][Full Text] [Related]
10. Regulation of the pro-angiogenic microenvironment by carboxyamido-triazole. Oliver VK; Patton AM; Desai S; Lorang D; Libutti SK; Kohn EC J Cell Physiol; 2003 Oct; 197(1):139-48. PubMed ID: 12942550 [TBL] [Abstract][Full Text] [Related]
11. Suppression of retinal neovascularization by shRNA targeting HIF-1alpha. Xia XB; Xiong SQ; Xu HZ; Jiang J; Li Y Curr Eye Res; 2008 Oct; 33(10):892-902. PubMed ID: 18853324 [TBL] [Abstract][Full Text] [Related]
12. Plasminogen kringle 5 inhibits alkali-burn-induced corneal neovascularization. Zhang Z; Ma JX; Gao G; Li C; Luo L; Zhang M; Yang W; Jiang A; Kuang W; Xu L; Chen J; Liu Z Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4062-71. PubMed ID: 16249481 [TBL] [Abstract][Full Text] [Related]
13. Potential anti-angiogenic role of Slit2 in corneal neovascularization. Han X; Zhang MC Exp Eye Res; 2010 Jun; 90(6):742-9. PubMed ID: 20298689 [TBL] [Abstract][Full Text] [Related]
14. mTOR inhibitor RAD001 (everolimus) has antiangiogenic/vascular properties distinct from a VEGFR tyrosine kinase inhibitor. Lane HA; Wood JM; McSheehy PM; Allegrini PR; Boulay A; Brueggen J; Littlewood-Evans A; Maira SM; Martiny-Baron G; Schnell CR; Sini P; O'Reilly T Clin Cancer Res; 2009 Mar; 15(5):1612-22. PubMed ID: 19223496 [TBL] [Abstract][Full Text] [Related]
15. Analysis of angiogenesis induced by cultured corneal and oral mucosal epithelial cell sheets in vitro. Kanayama S; Nishida K; Yamato M; Hayashi R; Sugiyama H; Soma T; Maeda N; Okano T; Tano Y Exp Eye Res; 2007 Dec; 85(6):772-81. PubMed ID: 17904552 [TBL] [Abstract][Full Text] [Related]
16. Expression of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in corneal lymphangiogenesis. Mimura T; Amano S; Usui T; Kaji Y; Oshika T; Ishii Y Exp Eye Res; 2001 Jan; 72(1):71-8. PubMed ID: 11133184 [TBL] [Abstract][Full Text] [Related]
18. A natural anti-inflammatory enone fatty acid inhibits angiogenesis by attenuating nuclear factor-κB signaling in vascular endothelial cells. Furuno A; Watari K; Nakamura M; Fukunaga Y; Jung JH; Ono M Int J Oncol; 2011 Feb; 38(2):493-501. PubMed ID: 21132269 [TBL] [Abstract][Full Text] [Related]
19. Effect of rapamycin alone and in combination with sorafenib in an orthotopic model of human hepatocellular carcinoma. Wang Z; Zhou J; Fan J; Qiu SJ; Yu Y; Huang XW; Tang ZY Clin Cancer Res; 2008 Aug; 14(16):5124-30. PubMed ID: 18698030 [TBL] [Abstract][Full Text] [Related]
20. Correlation of VEGF expression by leukocytes with the growth and regression of blood vessels in the rat cornea. Edelman JL; Castro MR; Wen Y Invest Ophthalmol Vis Sci; 1999 May; 40(6):1112-23. PubMed ID: 10235544 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]